Engineered oncolytic herpes virus inhibits ovarian and breast cancer metastases
A genetically reprogrammed Herpes simplex virus (HSV) can cure metastatic diffusion of human cancer cells in the abdomen of laboratory mice, according to a new study.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cold Sores | Genetics | Herpes | Laboratory Medicine | Ovarian Cancer | Ovaries | Science | Study